MediciNova Statistics

Total Valuation

MediciNova has a market cap or net worth of $106.43 million. The enterprise value is $64.61 million.

Market Cap	106.43M
Enterprise Value	64.61M

Important Dates

The next estimated earnings date is Thursday, February 13, 2025, after market close.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MediciNova has 49.05 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	49.05M
Shares Outstanding	49.05M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.98%
Owned by Institutions (%)	10.07%
Float	42.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.93
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.66, with a Debt / Equity ratio of 0.01.

Current Ratio	16.66
Quick Ratio	16.28
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.19% and return on invested capital (ROIC) is -12.39%.

Return on Equity (ROE)	-17.19%
Return on Assets (ROA)	-11.86%
Return on Capital (ROIC)	-12.39%
Revenue Per Employee	n/a
Profits Per Employee	-$791,845
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MediciNova has paid $3,047 in taxes.

Income Tax	3,047
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.10% in the last 52 weeks. The beta is 0.85, so MediciNova's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+39.10%
50-Day Moving Average	1.93
200-Day Moving Average	1.58
Relative Strength Index (RSI)	55.19
Average Volume (20 Days)	56,504

Short Selling Information

The latest short interest is 334,295, so 0.68% of the outstanding shares have been sold short.

Short Interest	334,295
Short Previous Month	351,747
Short % of Shares Out	0.68%
Short % of Float	0.79%
Short Ratio (days to cover)	11.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.98M
Pretax Income	-8.16M
Net Income	-10.29M
EBITDA	-11.96M
EBIT	-11.98M
Earnings Per Share (EPS)	-$0.21

Full Income Statement

Balance Sheet

The company has $42.28 million in cash and $457,126 in debt, giving a net cash position of $41.82 million or $0.85 per share.

Cash & Cash Equivalents	42.28M
Total Debt	457,126
Net Cash	41.82M
Net Cash Per Share	$0.85
Equity (Book Value)	55.07M
Book Value Per Share	1.12
Working Capital	40.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.21 million and capital expenditures -$875, giving a free cash flow of -$9.21 million.

Operating Cash Flow	-9.21M
Capital Expenditures	-875
Free Cash Flow	-9.21M
FCF Per Share	-$0.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MediciNova does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	-9.67%
FCF Yield	-8.65%

Analyst Forecast

The average price target for MediciNova is $9.00, which is 314.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	314.75%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	85.96%
EPS Growth Forecast (5Y)	-16.04%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MediciNova has an Altman Z-Score of 4.67 and a Piotroski F-Score of 1.

Altman Z-Score	4.67
Piotroski F-Score	1